Radiotherapy and Immunotherapy Combinations in Non-small Cell Lung Cancer: A Promising Future?

被引：8
|
作者：
Hanna, G. G. [1 ]
Illidge, T. [2 ]
机构：
[1] Queens Univ Belfast, Ctr Canc Res & Cell Biol, 95 Lisburn Rd, Belfast BT9 7AE, Antrim, North Ireland
[2] Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Canc Sci, Manchester Canc Res Ctr,Christie Hosp, Manchester, Lancs, England
来源：
CLINICAL ONCOLOGY | 2016年 / 28卷 / 11期
关键词：
Checkpoint inhibition; immunotherapy; NSCLC; radiotherapy; IMMUNE-RELATED RESPONSE; TUMOR MICROENVIRONMENT; IONIZING-RADIATION; SOLID TUMORS; MELANOMA; MODULATION; MECHANISMS; IPILIMUMAB; RESISTANCE; DOCETAXEL;
D O I：
10.1016/j.clon.2016.07.014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The goal of re-programming the host immune system to target malignancy with durable anti-tumour clinical responses has been speculated for decades. In the last decade such speculation has been transformed into reality with unprecedented and durable responses to immune checkpoint inhibitors seen in solid tumours. This mini-review considers the mechanism of action of immune modulating agents and the potential for combination with radiotherapy in the treatment of non-small cell lung cancer. (C) 2016 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：726 / 731
页数：6
相关论文
共 50 条
  • [41] Mini-review of conventional and hypofractionated radiation therapy combined with immunotherapy for non-small cell lung cancer
    Campbell, Allison M.
    Decker, Roy H.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2017, 6 (02) : 220 - 229
  • [42] Immunotherapy for Lung Cancer-Improving Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer With Immunotherapy
    Sun, Lova
    Aggarwal, Charu
    CANCER JOURNAL, 2020, 26 (06): : 548 - 554
  • [43] First line Immunotherapy for Non-Small Cell Lung Cancer
    Nasser, Nicola J.
    Gorenberg, Miguel
    Agbarya, Abed
    PHARMACEUTICALS, 2020, 13 (11) : 1 - 24
  • [44] Immunotherapy in Small Cell Lung Cancer Treatment: a Promising Headway for Future Perspective
    Walia, Harleen Kaur
    Sharma, Parul
    Singh, Navneet
    Sharma, Siddharth
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (02) : 268 - 294
  • [45] Predicting response to immunotherapy in non-small cell lung cancer- from bench to bedside
    Montoya, Chris
    Spieler, Benjamin
    Welford, Scott M.
    Kwon, Deukwoo
    Pra, Alan Dal
    Lopes, Gilberto
    Mihaylov, Ivaylo B.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [46] Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancer
    Duchemann, Boris
    Remon, Jordi
    Naigeon, Marie
    Cassard, Lydie
    Jouniaux, Jean Mehdi
    Boselli, Lisa
    Grivel, Jonathan
    Auclin, Edouard
    Desnoyer, Aude
    Besse, Benjamin
    Chaput, Nathalie
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (06) : 2937 - 2954
  • [47] Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer
    Huang, Dingzhi
    Lin, Gen
    Chu, Qian
    Hu, Yi
    Wang, Jun
    Wang, Zhijie
    Yang, Fan
    Zhong, Wenzhao
    Zhou, Chengzhi
    Zhu, Bo
    Ai, Xinghao
    Cao, Baoshan
    Cao, Yabing
    Chen, Mingqiu
    Chen, Xiaohui
    Chu, Tianqing
    Duan, Jianchun
    Fan, Yun
    Fang, Yong
    Feng, Shuitu
    Feng, Weineng
    Guo, Hui
    Han, Chengbo
    He, Yong
    Hong, Shaodong
    Hu, Jie
    Huang, Meijuan
    Huang, Yan
    Jiang, Da
    Jiang, Kan
    Jiang, Richeng
    Jin, Bo
    Jin, Shi
    Li, Jisheng
    Li, Min
    Li, Ziming
    Li, Chao
    Lin, Jie
    Liu, Anwen
    Liu, Si-Yang Maggie
    Liu, Yutao
    Liu, Zhefeng
    Liu, Zhe
    Liu, Zhenhua
    Liu, Zhentian
    Liu, Zhigang
    Lu, Yuping
    Lv, Tangfeng
    Ma, Zhiyong
    Miao, Qian
    THORACIC CANCER, 2023, 14 (34) : 3421 - 3429
  • [48] The surgical perspective in neoadjuvant immunotherapy for resectable non-small cell lung cancer
    Jiang, Long
    Huang, Jia
    Jiang, Shanshan
    Rong, Wenwen
    Shen, Yaofeng
    Li, Chongwu
    Tian, Yu
    Ning, Junwei
    Chen, Xiaoke
    Yang, Yunhai
    Ding, Zhengping
    Li, Ziming
    Luo, Qingquan
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (08) : 2313 - 2321
  • [49] The Evolving Role of Immunotherapy in Stage III Non-Small Cell Lung Cancer
    Perdrizet, Kirstin
    Cheema, Parneet K.
    CURRENT ONCOLOGY, 2021, 28 (06) : 5408 - 5421
  • [50] Radiotherapy and Immunotherapy Combinations for Lung Cancer
    Agrawal, Vishesh
    Benjamin, Kimberly Thomas
    Ko, Eric C.
    CURRENT ONCOLOGY REPORTS, 2021, 23 (01)
12345